1. The pitch Luminik is building an AI co-pilot for event marketers to help B2B marketing teams turn expensive conferences into predictable pipeline - by fixing targeting, meetings, and follow-up with one revenue-first system. 2. The what B2B companies spend 20–30% of their marketing budget on events - but most can’t prove the ROI. Attendee lists come in late. Sales teams scramble to book meetings. Post-event follow-up is messy and untracked. As a result, 40–70% of event-generated leads disappear. This affects CMOs, event marketers, and sales teams who are under pressure to justify spend and show pipeline impact. The pain is felt across industries, and the budgets at stake are massive. 3. The how Luminik is an AI-powered event marketing co-pilot. It identifies ICP accounts and decision-makers weeks in advance, helps lock meetings before the event, alerts sales when high-value prospects show up at the booth, and auto-syncs all activity back to the CRM. No more manual scraping, badge scans, or spreadsheet reporting. We turn events into a pipeline channel your CFO will actually trust - with math, not guesswork. 4. The why We saw the same pattern over and over while working with fast-growing SaaS teams: events were expensive, chaotic, and disconnected from revenue. I have helped teams wrangle messy data for years - and realized we could bring clarity, structure, and impact to one of the most broken (yet high-stakes) parts of B2B marketing. We’re here to fix event marketing with a revenue-first lens - because if you can’t tie events to pipeline, your budget is always at risk.

Impact StartUp er Norges ledende akselerator for sosiale og miljøretta startups. Vårt primære mål er å hjelpe impact-selskaper å bli forretningsmessige tidligere, så enda flere lykkes. Vår innsats skjer gjennom omfattende kunnskaps- og kompetansetilbud, tilgang til riktig type kapital, samt relevant nettverks- og kunnskapsarena. Impact-selskaper spiller en nøkkelrolle i å skape positive samfunnsendringer. Stadig flere starter bedrifter for å løse samfunnsproblemer der samfunnseffekten vokser i takt med kommersielle mål. Det er et nytt næringsliv som er i stor vekst, der målbar samfunnseffekt blir den mest verdifulle valutaen i fremtiden.

IZX is a platform for integrating LLMs into business applications, enabling natural language understanding and automation. Our product streamlines the creation, inference, and scaling of enterprise foundational models (that can also be hosted on-premise or in private cloud) that interact with external LLMs, APIs, and data sources. Our team includes the top 1% of AI/ML engineers in Europe. Join our team!

INFINITE is integrating solar cells into the body of lightweight vehicles. When exposed to sun irradiation, these cells will generate electricity to recharge the vehicle battery. Up to 600 kWh by year can be produced in a city like Rome. A light vehicle consuming 60 W/km can achieve up to 10 000 km per year from solar energy, which is more than the yearly average distance travelled in an urban area.

BOVI dekker høyfrekvente mobilitetsbehov i og rundt by- og stedskjernen med trygge, miljøvennlige og brukerorienterte løsninger tilpasset offentlige og andre strategiske relasjoners behov. Bovi mobilitet tilbyr et konsept som ivaretar dagens opplevde problemer knyttet til mikromobilitet, Hastighetsregulering, Ryddig parkering, Trygghet og sikkerhet, Miljø, og bærekraft Automatisk hastighetsregulering. Behovsprøvet og regulert parkering Trygg og sikker mobilitet

Simula Consulting is a tech consulting company aiming to redefine what is possible through digitalization and bridging the gap between academic discoveries and real-world challenges. This is achieved through offering advisory and development services across four ICT areas: machine learning, scientific computing, software engineering, and mobile networks. Our services are delivered by highly experienced and qualified personnel that form the backbone of Simula; the highest-ranked ICT institution in Norway. With each project and engagement we take on, we thoughtfully assemble a bespoke team of consultants who work closely with our clients to solve complex real-world problems.

Our SURF scooters are loved by both our customers and the earth. We make the world a better place by enabling people to SURF their streets on clean energy! SURF Rides AS er et norsk mikromobilitetsselskap fra Oslo. Reinventing micromobility for greater good🏄 Vi hjelper våre brukere å reise på e

Chasing the New NormalWe build exponential companies that chase the new normal of their industry by redefining business models with the use of software & technology made by diverse teams resulting in extraordinary returns. Our mission is to build exponential software and software-enabled companies that chase the New Normal of their industries. We are driven by our passion to develop the potential within people and the technology created by them.

Ditt neste eventyr starter her Rebil er et nytt bruktbilkonsept, hvor kundene får sin nye bruktbil levert hjem på døren med noen få klikk på nett. Rebils ambisjon er å gjøre bruktbil enkelt og trygt med en sømløs kundereise. Etter en pangstart fra lansering sist år er vi nå klare for å gire opp. Vi vokser kraftig og mulighetene hos oss er mange for deg med et ønske om å utfordre det etablerte!Om Rebil Rebil er en ny og annerledes aktør innen bruktbil. Alle våre kunder kan bestille sin nye bruktbil på nett og få den raskt levert på døren. Kunden får:  Gratis levering: Bilen levert hjem helt gratis innen 24 timer Åpent kjøp: 14 dager åpent kjøp og alle pengene tilbake hvis de ombestemmer seg  Ingen overraskelser: Grundig tilstandssjekk, komplett service og minimum 6 mnd garanti Bilene som kjøpes inn blir nøye inspisert og istandsatt, hvor vi til og med viser evt. gjenværende bruksmerker til kunden for fullstendig åpenhet. Bak Rebil står Askeladden & Co. Askeladden starter og skalerer selskaper, og står bak selskaper som legeklinikken Dr. Dropin, massasjekjeden Squeeze, tannlegeklinikken Blid, pizzakjeden Digg og mange flere.

High-quality cargo bikes and high-tech solutions for urban mobility. Bogbi is a  Norwegian-Colombian startup that produces cargo bikes in Bogota for the national and international markets with a strong integrated social impact. Our bikes are handmade by Norwegian industrial designer Johannes Hegdahl and Colombian engineer David Duarte, as well as excellent welders and other local providers of components and engineering here in Bogota. In all moderation, we are being told that we have developed a world-class product. At Bogbi we want our bikes to contribute to Colombia's future in peace. Together with the Norwegian Refugee Council, and the Colombian company Mejor en Bici we are setting up a pilot -project to provide vocational training for young people involved in the conflict to become welders, entrepreneurs and eventually work with us to develop what we call: bike magic from Colombia. To increase our impact on society and the environment we have teamed up with the Norwegian organization International Development Norway and Innovation Norway. Together we will develop a digital platform for last-mile delivery service. This will enable companies to bring goods from business to business using cargo bikes and create employment for vulnerable groups, as well. We were accepted to apply for Innovation Norway's vision 2030 grants to develop a last-mile delivery service in Bogota and around the world. The grant is for three years to develop software and bikes to establish a b2b pilot here in Bogota with international We are located in Bogota with our own production facility and capacity to produce up to 40 bikes per month.

The Founder Institute is the world’s premier startup launch program for talented entrepreneurs. If you are up to the challenge, our comprehensive step-by-step program will give you the structure, mentor support, and network of entrepreneurs you need to start an enduring company. Based in Silicon Valley and with chapters across 60 countries, the Founder Institute's mission is to "Globalize Silicon Valley" and build sustainable startup ecosystems worldwide.

Otivio’s main product, FlowOx™, is addressing chronic wounds with focus on peripheral arterial disease (PAD), which is a serious condition leading to pain, chronic wounds and in many cases amputation and mortality. The patient population is very large and increasing. There are limited adequate treatment options offered to the patients aside from surgical interventions. FlowOx™ is a non-invasive product intended for home use. Long-term patient testing in more than 50 patients documents increased blood flow, reduced pain and wound healing. FlowOx™ is CE marked. In fourth quarter 2017 had its commercial break-through through sales of FlowOx to public customers.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

BusinessClass.com is a sophisticated travel tech startup. Our vision is to become the global leader in premium travel by offering the best travel search, the best travel offers, as well as world-class reviews and other inspirational content. BusinessClass.com is targeting the more quality-minded travellers who want the best travel products at the best possible prices. BusinessClass.com is suitable for both corporate & leisure travel, offering top-quality airline tickets and accommodation. The team and advisers at BusinessClass.com have extensive travel tech industry knowledge. Founder Jason Eckhoff was EY Entrepreneur Of The Year in 2013 when his first online travel company had beaten 28.000 growth companies over a 4-year period. BusinessClass.com is (other than the founder/CEO) backed by a former C-level manager of a major airline and a co-founder of a unicorn (a company valued at more than 1 USD billion). We are currently considering raising additional risk capital for further developing BusinessClass.com and creating the world's best search engine for premium travel!

Instant cooperation with emergency callers and with patients. You and your team deserve to have the best tools for learning. We prepare you for high-intensity meetings with patients and for time-intensive interactions with other healthcare professionals. Communication in high-intensity situations. For experienced health care professionals.